Insider Trading History of Duvall Diantha

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Duvall Diantha since 2017. This trader's CIK number is 1696784. At the time of last reporting, Duvall Diantha was the CHIEF FINANCIAL OFFICER of Genocea Biosciences, Inc.. (stock ticker symbol GNCA). Also see all insider trading activities at Genocea Biosciences, Inc..

Note that in the past Duvall Diantha also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Genocea Biosciences, Inc. (GNCA) by Duvall Diantha

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 GNCA 0 $0 30,953 $6,404 0 $0

Yearly summary of insider trading at Bioverativ Inc. (BIVV) by Duvall Diantha

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 BIVV 0 $0 0 $0 1,390 $0
2017 BIVV 0 $0 818 $49,464 0 $0


Insider trading activities at 2 companies by Duvall Diantha:

1. Genocea Biosciences, Inc. (GNCA)

2. Bioverativ Inc. (BIVV)

Table 1. Insider trading of Genocea Biosciences, Inc. (GNCA) by Duvall Diantha

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-06-02 GNCA Sale 1,355 .06 81
2022-06-02 GNCA Sale 1,355 .06 81
2022-05-26 GNCA Sale 24,407 .08 1,879
2022-04-04 GNCA Sale 963 1.25 1,203
2022-03-16 GNCA Sale 2,873 1.10 3,160

Table 2. Insider trading of Bioverativ Inc. (BIVV) by Duvall Diantha

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-02-14 BIVV Option Ex 1,390 .00 0
2017-06-28 BIVV Sale 818 60.47 49,464

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Duvall Diantha (CHIEF FINANCIAL OFFICER of Genocea Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.